The global dermatophytic onychomycosis treatment market size is predicted to reach USD 6.63 billion by 2028, exhibiting a CAGR of 7.4% during the forecast period. The rising prevalence of diabetes and incidences of chronic nail fungus infection will lead to heavy demand for dermatophytic onychomycosis treatment, which, in turn, will foster the growth of the market, it is mentioned in a report, titled “Dermatophytic Onychomycosis Treatment Market Size, Share & COVID-19 Impact Analysis, By Product Type (Tablets and Nail Paints), By Route of Administration (Oral and Topical), By Type (Prescribed and Over-the-Counter (OTC)), By Distribution Channel (Hospitals & Clinics, Retail Pharmacies, and Online Channels), and Regional Forecast, 2021-2028” the market size stood at USD 3.74 billion in 2020.
Request for Free Sample Report PDF @ https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/dermatophytic-onychomycosis-treatment-market-103310
Increasing Prevalence of Onychomycosis to Aid Expansion in North America
The market size in North America stood at USD 1.65 billion in 2019. The growth in the region is attributed to rising cases of onychomycosis in the region. The growing R&D activities will further foster the growth of the market in the region. The increasing demand for Jublia will accelerate the growth of the market in the region. Europe is predicted to witness a high growth rate during the forecast period owing to the favorable health reimbursement policies in European countries such as Italy, Spain, and the U.K. The superior distribution of OTC drugs retail pharmacies such as Walgreens, and others will enable speedy expansion of the market in Europe. According to an article published in the Journal of the European Academy of Dermatology and Venereology, the prevalence of onychomycosis in Europe is 4.3%.
The Report Lists the Main Companies in the Dermatophytic Onychomycosis Treatment Market:
- Bausch Health Companies Inc.
- Pfizer Inc.
- GlaxoSmithKline plc
- Janssen Pharmaceuticals, Inc.
- Cipla Inc.
- Kaken pharmaceuticals Co., Ltd.
- Other Prominent Players
Continued. . .
Related Article @
NOTE: Our team is studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. We aim to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245